COVID and beyond: labs unite to boost genomic surveillance globally Two laboratories in Britain and South Africa, which were at the forefront of tracking new coronavirus variants during the pandemic, have teamed up to keep the focus on genomic surveillance globally as the COVID emergency recedes. Jennifer Rigby Reuters

...

At-risk patients often not offered antivirals for COVID-19, analysis shows Jenni Konrad/ Flickr cc CIDRAP

Four out of five Veterans Affairs (VA) patients who had mild COVID-19 but had compromised immune systems were not offered the use of COVID antivirals, according to a study today in Morbidity and Mortality Weekly Report.

South America dengue spike prompts vaccination drive as bug spray runs out | Reuters

Native American Communities Have the Highest Suicide Rates, Yet Interventions Are Scarce - KFF Health News Native Americans die by suicide at a higher rate than any other racial or ethnic group, yet research into effective and culturally appropriate interventions is uncommon. khnkytjaw KFF Health News

...

World risks missing deadline for pandemic accord, says WHO chief

COVID-19 infection in pregnancy may raise baby's risk of respiratory illness - UPI.com Babies born to COVID-infected mothers have triple the risk of developing a breathing disorder that normally affects preemies, a new study shows. UPI

...

Researchers found that exposure to the coronavirus while in the womb increased a newborn's risk of respiratory distress syndrome by sparking an "inflammatory cascade" in the infants that affected their breathing. 

...

Study: Vaccinated patients have lower risk of long COVID At 90-days post-infection, 8% of vaccinated cases were still reporting symptoms, compared with 27% of unvaccinated cases. CIDRAP

Today researchers from the University of Michigan published in Open Forum Infectious Diseases more evidence that being vaccinated against COVID-19 significantly reduces the risk of developing long COVID.

...

‘On par with cancer and heart disease’: Experts, patients warn Congress about the burden of long COVID as the government blows through $1.15 billion without finding a cure There’s a strong argument to be made for the government to provide the funding–and then mostly get out of the way. Yahoo Finance

...

WHO grants emergency listing for Corbevax COVID vaccine Non-exclusive licensing of the yeast strain by developers will allow others to develop effective, low-cost vaccines. CIDRAP

The World Health Organization (WHO) has approved another COVID-19 vaccine for emergency use listing (EUL): Corbevax, a recombinant protein–based vaccine developed by scientists at Texas Children's Hospital and Baylor College of Medicine.